Biomimetic Cell Membrane-Engineered Covalent Organic Frameworks for Smart Drug Delivery: Design Principles, Engineering Strategies, and Translational Challenges
Pharmaceutics · 06.11.2026 · 18 (11) · 1445
DOI: 10.3390/pharmaceutics18111445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 06.11.2026. Verfasst von Hina Ali und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Huanghe Science and Technology College.
Abstract (Originalsprache)
Covalent organic frameworks (COFs) have attracted growing interest as drug delivery platforms owing to their ordered porosity, tunable pore architecture, and versatile chemical functionality. Favorable physicochemical characteristics alone, however, do not guarantee effective performance in vivo, and biomimetic membrane engineering has emerged as a strategy for modifying the biological interface of COF nanocarriers. This review develops a principle-based framework structured around five interconnected concepts: biological identity transfer, functional mimicry, homotypic targeting, biophysical compatibility, and programmable responsiveness. Rather than treating membrane coating as a universally beneficial modification, it examines how far these functions depend on membrane source, retained biomolecules, membrane orientation, coating quality, and the properties of the underlying framework. Ten primary membrane-engineered COF systems are compared quantitatively across framework chemistry, membrane source and coating method, particle characteristics, cargo loading, release behavior, biological model, pharmacokinetics, therapeutic outcomes, safety, and study limitations. Five membrane-engineering strategies are evaluated against defined fabrication, scalability, integrity, targeting, cost, and regulatory criteria, distinguishing throughout evidence obtained directly in COF systems from findings extrapolated from other nanocarriers. Translational barriers, including donor variability, membrane integrity, immunogenicity, sterility, framework degradation, batch reproducibility, and regulatory requirements, are examined. Current evidence supports preclinical feasibility but not established translational readiness.
Förderung
- Huanghe Science and Technology College
Zitieren
APA
Ali, H., Khan, H., Muhammad, J., Zohaib, H. M., & Khan, A. (2026). Biomimetic Cell Membrane-Engineered Covalent Organic Frameworks for Smart Drug Delivery: Design Principles, Engineering Strategies, and Translational Challenges. Pharmaceutics, 18(11), 1445. https://doi.org/10.3390/pharmaceutics18111445
Vancouver
Ali H, Khan H, Muhammad J, Zohaib HM, Khan A. Biomimetic Cell Membrane-Engineered Covalent Organic Frameworks for Smart Drug Delivery: Design Principles, Engineering Strategies, and Translational Challenges. Pharmaceutics. 2026;18(11):1445. doi:10.3390/pharmaceutics18111445
BibTeX
@article{Ali2026,
author = {Ali, Hina and Khan, Hayat and Muhammad, Javed and Zohaib, Hafiz Muhammad and Khan, Adil},
title = {Biomimetic Cell Membrane-Engineered Covalent Organic Frameworks for Smart Drug Delivery: Design Principles, Engineering Strategies, and Translational Challenges},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1445},
doi = {10.3390/pharmaceutics18111445}
}
EUVIMED